title: Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban.
authors.affiliation: Clinical Pharmacology, Department of Public Health, University of Southern Denmark, Odense C, Denmark.
authors.forename: Maja
authors.initials: M
authors.lastname: Hellfritzsch
authors.affiliation: Clinical Pharmacology, Department of Public Health, University of Southern Denmark, Odense C, Denmark.|Department of Clinical Chemistry and Pharmacology, Odense University Hospital, Odense C, Denmark.
authors.forename: Per
authors.initials: P
authors.lastname: Damkier
authors.affiliation: Clinical Pharmacology, Department of Public Health, University of Southern Denmark, Odense C, Denmark.
authors.forename: Anton
authors.initials: A
authors.lastname: Pottegård
authors.affiliation: Institute of Rational Pharmacotherapy, Danish Health and Medicines Authority, Copenhagen S, Denmark.
authors.forename: Thor
authors.initials: T
authors.lastname: Grønlykke
authors.affiliation: Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
authors.forename: Erik L
authors.initials: EL
authors.lastname: Grove
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000652:urine; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D007674:Kidney Diseases / Q000652:urine; D007677:Kidney Function Tests; D008657:Metabolic Clearance Rate; D011720:Pyrazoles / Q000009:adverse effects / Q000652:urine; D011728:Pyridones / Q000009:adverse effects / Q000652:urine
chemical_list: D000925:Anticoagulants; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban